Identification and characterization of two chloramphenicol glucuronides from the in vitro glucuronidation of chloramphenicol in human liver microsomes

被引:16
作者
Chen, M.
Howe, D.
Leduc, B.
Kerr, S.
Williams, D. A.
机构
[1] CombinatoRx Inc, Dept Preclin Dev & Formulat, Cambridge, MA 02142 USA
[2] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA USA
[3] Vertex Pharmaceut Inc, Drug Innovat Pharmacokinet Dept, Cambridge, MA USA
关键词
chloramphenicol; human liver microsomes; glucuronidation; enzyme kinetics; chloramphenicol O-glucuronides; liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS); DRUG-METABOLISM; TOXICITY; DISPOSITION; MODEL;
D O I
10.1080/00498250701620734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study reports the development of a specific and sensitive liquid chromatography coupled with tandem mass spectrometry detection (LC-MS/MS) assay for the quantification of the in vitro O-glucuronidation of chloramphenicol (Cl?), the determination of the kinetic parameters for the O-glucuronidation of CP in pooled human liver microsomes (HLM), the biosynthesis of the CP glucuronides (CPGlu), and identification of the structures of CPGlu by H-1-nuclear magnetic resonance (NMR) and MS. Two glucuronyl derived metabolites of CP were obtained from the incubation of alamethicin-activated HLM with CP and uridine 5'-diphosphoglucuronic acid (UDPGA) in pH 7.4 TRIS buffer. Their identification and structural confirmation were achieved by beta-glucuronidase hydrolysis, in the presence and absence of UDPGA, and by H-1-NMR and LC-MS/ MS. These two metabolites were biosynthesized, isolated, and purified using high-performance liquid chromatography (HPLC). Their structures were further identified as the 1-O-CPGlu (the minor glucuronide formed at the secondary alcohol of CP) and 3-O-CPGlu (the major glucuronide formed at the primary alcohol of CP) by LC-MS/MS and two-dimensional NMR. The enzymatic kinetic parameters K-m and V-max in HLM for the 3-O-CPGlu were determined to be 650 mu M and 0.26 nmoles min(-1) mg(-1), respectively, and for the 1-O-CPGlu to be 301 mu M and 0.014 nmoles min(-1) mg(-1), respectively. This study also provides a sensitive and specific method for the measurement of in vitro CP-UDP-glucuronosyltransferase (UGT) activity.
引用
收藏
页码:954 / 971
页数:18
相关论文
共 25 条
[1]   CHLORAMPHENICOL [J].
BROCK, TD .
BACTERIOLOGICAL REVIEWS, 1961, 25 (01) :32-+
[2]  
Brook Itzhak, 2004, Expert Rev Anti Infect Ther, V2, P153, DOI 10.1586/14787210.2.1.153
[3]  
CHAMBERS HF, 2006, GOODMAN GILMANS PHAR, P1179
[4]  
Cornish-Bowden A., 2004, FUNDAMENTALS ENZYME, P113
[5]   GREY-TODDLER - CHLORAMPHENICOL TOXICITY [J].
CRAFT, AW ;
BROCKLEBANK, JT ;
HEY, EN ;
JACKSON, RH .
ARCHIVES OF DISEASE IN CHILDHOOD, 1974, 49 (03) :235-237
[6]   CLINICAL PHARMACOKINETICS OF PROBENECID [J].
CUNNINGHAM, RF ;
ISRAILI, ZH ;
DAYTON, PG .
CLINICAL PHARMACOKINETICS, 1981, 6 (02) :135-151
[7]  
DAYTON PG, 1963, J PHARMACOL EXP THER, V140, P278
[8]  
Glazko A J, 1966, Antimicrob Agents Chemother (Bethesda), V6, P655
[9]   EARLY ADVENTURES IN DRUG-METABOLISM .3. CHLORAMPHENICOL [J].
GLAZKO, AJ .
THERAPEUTIC DRUG MONITORING, 1987, 9 (03) :320-330
[10]  
HOLT D, 1993, ADVERSE DRUG REACT T, V12, P83